Huan Ming Chen

Director Ejecutivo en Shanghai Zhimeng Biopharma, Inc. .

Health Technology

Perfil

Huan Ming Chen is the founder of Shanghai Zhimeng Biopharma, Inc. He holds the title of President & Chief Executive Officer since the company's founding in 2015.

Cargos activos de Huan Ming Chen

Empresas	Cargo	Inicio
Shanghai Zhimeng Biopharma, Inc. Shanghai Zhimeng Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Shanghai Zhimeng Biopharma, Inc. is a clinical-stage biopharmaceutical company located in the resource-rich Zhangjiang High Tech Park of Shanghai, China. The Chinese company is committed to developing innovative drugs for the treatment of chronic hepatitis B (CHB) and severe neurological diseases with significant unmet medical needs. Founded in 2017, Zhimeng Pharmaceutical Technology Co., Ltd. is a biotechnology company dedicated to the development of drugs for the treatment of CHB and related liver diseases. The company was founded by Huan Ming Chen, Zhi Jun Zhang, and Bo Liang, with Huan Ming Chen serving as the CEO since 2015.	Director Ejecutivo	26/10/2015

Todos los cargos activos de Huan Ming Chen

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Huan Ming Chen.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Shanghai Zhimeng Biopharma, Inc. Shanghai Zhimeng Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Shanghai Zhimeng Biopharma, Inc. is a clinical-stage biopharmaceutical company located in the resource-rich Zhangjiang High Tech Park of Shanghai, China. The Chinese company is committed to developing innovative drugs for the treatment of chronic hepatitis B (CHB) and severe neurological diseases with significant unmet medical needs. Founded in 2017, Zhimeng Pharmaceutical Technology Co., Ltd. is a biotechnology company dedicated to the development of drugs for the treatment of CHB and related liver diseases. The company was founded by Huan Ming Chen, Zhi Jun Zhang, and Bo Liang, with Huan Ming Chen serving as the CEO since 2015.	Health Technology